The Power of Predictive AI Models: Revolutionizing Cancer Research

Powerful computational tools, such as predictive artificial intelligence (AI) models, are reshaping preclinical research, leading to more optimized and streamlined drug discovery and drug development pipelines.1 In drug discovery, AI can be applied...

Read More

Functional Precision Oncology: Filling the Gap Left By Genomics-Based Approaches

Precision oncology (also known as personalized medicine in cancer treatment) is about matching an individual to the optimal therapy for their unique form of cancer. Many people associate personalized medicine with genetic testing. Genomic tumor...

Read More

For Immediate Release: Upcoming Webinar on AI in Cancer Research

OPTIMIZING BIOMARKER DISCOVERY, MODEL SELECTION AND PRECLINICAL DECISION-MAKING Toronto, ON — April 25, 2023 — In this upcoming live webinar hosted by Xtalks, learn about how artificial intelligence (AI) can bring greater speed and precision to...

Read More

FOR IMMEDIATE RELEASE: CERTIS ONCOLOGY SOLUTIONS LAUNCHES PREDICTIVE ANALYTICS PLATFORM

Bioinformatics Solution Combines Artificial Intelligence, Maching Learning and Functional Testing to Elevate Precision Cancer Treatment   

Read More

FOR IMMEDIATE RELEASE: Certis Oncology Solutions Announces Three Abstracts Accepted for Presentation at AACR Annual Meeting

Presentations to highlight the value of clinically relevant patient-derived xenograft (PDX) models for translational research and drug development  

Read More

How to Overcome the Translation Gap in Cancer Research

Custom Solutions, Better Translation The ultimate goal of drug development in oncology is to identify drug candidates that will successfully advance through the clinical trial pipeline to FDA approval, thus offering individuals with cancer the hope...

Read More

Innovations in Model Development - Upcoming Certis and Xtalks Webinar

In this educational webinar, learn about the latest innovations in preclinical cancer modeling. This talk will cover advancements in patient-derived xenograft (PDX) development, models of spontaneous metastases and other sophisticated approaches to...

Read More

Mimicking the "Seed and Soil:" The State of PDX Models of Breast Cancer Metastases

Why do the quaintest analogies stick to biology’s most morbid phenomena? Look no further than English surgeon Stephen Paget’s “seed and soil” model for breast cancer metastasis for a prototypical example. In his 1889 publication in the Lancet, Paget...

Read More

Certis Oncology Solutions Releases New Cancer Model Database, BarneyOI

San Diego, CA — Certis Oncology Solutions, a life science technology company, announced today the release of its new cancer model database, BarneyOI™. This proprietary, online repository houses deep molecular characterization data for Certis’...

Read More

New Certis Whitepaper: Bringing Certainty to PDX Model Characterization

EXECUTIVE SUMMARY Patient-derived xenograft (PDX) models are indispensable for translational cancer research. However, public and private PDX tumor banks may lack standard quality controls, which may lead to genomic and transcriptomic...

Read More